Q4 2022 Rani Therapeutics Holdings Inc Earnings Call Transcript
Hello, and welcome to Rani Therapeutics fourth quarter and full year 2022 financial results and corporate update conference call. (Operator Instructions) As a reminder, this call is being recorded today, wednesday, March 22, 2023. I would now like to turn the conference over to Lawrence Watts of Gilmartin Group. Please go ahead, sir.
Thank you, operator. Joining us on the call today from Rani Therapeutics are Chief Executive Officer, Talat Imran, Chief Financial Officer, Svai Sanford, and Chief Scientific Officer, Mir Hashim. During this conference call, management will make forward-looking statements that are subject to risks, uncertainties, and assumptions such as but not limited to those discussed in the Risk Factors section of the company's filings with the Securities and Exchange Commission, including its annual report on Form 10-K and quarterly reports on Form 10-Q, which identify the specific factors that may cause actual events or results to differ materially from those described in these forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
